To: Shoe who wrote (1816 ) 12/8/1997 7:37:00 PM From: Jeffrey L. Henken Respond to of 4356
Nice try Shoe. I suspect that you will never be fully satisfied when it comes to answering questions about the polymer. I doubt even Foster-Miller and Cyclopss have finalized the details to such a high degree. Even if they had this information it would not be available for public consupmtion. How about I simply reprint the novel polymer press release and we just go on believing that these two companies really can both ultimately profit from this venture. If that's not good enough you will have to call the companies yourself. Good luck getting an answer. If this seems offensive to you I am sorry but I have Never seen the details of any joint venture discussed on any thread at SI much less in a company press release. No matter how expensive the polymer may be the cost can be lowered through economies of scale. In other words the more you make the less it costs. The other shoe has dropped. Game over. I'm too tired to play anymore! Here's that press release: 10/02 18:09 NOVEL POLYMER CREATED FOR AEROSPACE INDUSTRY TO HIT MARKET SOON ( BW)(CYCLOPSS)(OZON) Novel Polymer Created for Aerospace Industry to Hit Market Soon Business Editors, Health/Medical Writers SALT LAKE CITY--(BW HealthWire)--Oct. 2, 1997--A new, lightweight material which is economically processed and extremely strong and heat resistant has been developed for use in aerospace, was announced Thursday by Cyclopss Biochemical Corp. and Foster-Miller Inc. Specific applications include jet engine components as well as aircraft and spacecraft structural components. The two companies today inked a Limited Liability Corporation ("LLC") to commercialize the new high performance polymer system. The material could fill a critical need in the aerospace industry and is now undergoing qualification testing as part of a NASA grant. Most of the current high temperature systems suffer from drawbacks including difficulty in processing and negative health and environmental impacts. The LLC, PYROGONN Inc., is the culmination of years of research and development. The project began in 1982 when Cyclopss Biochemical Corp. was contracted by McDonnell Douglas Astronautics to develop a process to manufacture a monomer which held promise in the aerospace industry. The study resulted in a process patent which is now held by the LLC. Major companies such as Hercules Inc. and Thiokol Inc. have shown significant interest in the monomer over the years. Foster-Miller has now succeeded in formulating a resin system which utilizes the material to produce the composite product. Cyclopss Corp. (NASDAQ:OZON) located in Salt Lake City is the parent company of Cyclopss Biochemical Corp., a manufacturer of high quality specialty chemicals and pharmaceutical intermediates. Cyclopss Corp. is a leader in the development and application of ozone-based systems. Ozone is one of the most effective disinfectants and oxidants and has begun to replace chlorine and other environmentally-unfriendly disinfectants. Cyclopss has recently been in the news because of its ozone technology that kills e.coli and other microbes and bacteria found in some foods. Foster-Miller Inc. is a technology development firm based in Waltham, Mass. and provides research and development services directed towards novel materials and specialized machinery, including robotics, and materials research for clients in government, aerospace, utilities and other commercial environments. --30--jbm/ix* kjs/ix CONTACT: Cyclopss Corp., Salt Lake City William Stoddard, 801/972-9090 or Foster-Miller Inc., Waltham Jay Boyce, 617/290-0092